Overview
Osteoarthritis of the sternoclavicular joint (SCJ) is a degenerative condition affecting the articulation between the clavicle and sternum, crucial for shoulder girdle stability and load transmission. This condition predominantly affects older adults, though it can occur at any age, leading to significant pain, functional impairment, and reduced quality of life. Patients often present with localized pain, swelling, and symptoms that may radiate to the neck, chest, or shoulder, impacting daily activities and work. Early recognition and appropriate management are critical in mitigating long-term disability, making accurate diagnosis and tailored treatment strategies essential in day-to-day clinical practice 1.Pathophysiology
Osteoarthritis in the SCJ arises from progressive degeneration of articular cartilage, characterized by the breakdown of proteoglycans and collagen, leading to cartilage thinning and eventual exposure of subchondral bone. This process triggers an inflammatory response, attracting synovial cells and macrophages that release cytokines and enzymes such as matrix metalloproteinases (MMPs), further degrading the joint structures. Osteophytes (bone spurs) may form as a compensatory mechanism, but they often contribute to mechanical irritation and pain. Additionally, degeneration of the intra-articular disc can lead to instability and additional mechanical stress on the joint, exacerbating symptoms 1.Epidemiology
The incidence of symptomatic SCJ osteoarthritis is relatively low compared to other joints, primarily affecting individuals over 50 years of age, with a slight female predominance. Prevalence increases with age, reflecting the cumulative wear and tear on the joint. Geographic and occupational factors may influence risk, with repetitive overhead activities or trauma potentially contributing to earlier onset or more severe symptoms. However, specific incidence and prevalence figures are not widely reported, highlighting the need for more comprehensive epidemiological studies 1.Clinical Presentation
Patients with SCJ osteoarthritis typically present with chronic, localized pain over the sternoclavicular region, often exacerbated by shoulder movements or arm elevation. Common symptoms include tenderness, swelling, and sometimes crepitus upon movement. Pain may radiate to the neck, shoulder, or chest, mimicking other musculoskeletal or thoracic conditions. Red-flag features include significant swelling, signs of infection (fever, erythema), or instability of the joint, which warrant urgent evaluation to rule out more serious pathologies such as septic arthritis or traumatic injury 1.Diagnosis
The diagnostic approach for SCJ osteoarthritis involves a thorough clinical evaluation complemented by imaging studies. Key steps include:
Clinical Evaluation: Detailed history focusing on duration, nature, and aggravating factors of pain, along with physical examination assessing tenderness, swelling, and range of motion limitations.
Imaging:
- Computed Tomography (CT): Essential for assessing bony changes, osteophytes, and joint space narrowing.
- Magnetic Resonance Imaging (MRI): Useful for evaluating soft tissue structures, including the intra-articular disc and synovitis.
Diagnostic Injection: Ultrasound-guided injection of local anesthetic to confirm SCJ as the primary pain generator, with a positive response indicating a high likelihood of SCJ pathology.
Specific Criteria:
- Chronic pain ≥12 months duration 1.
- Failure of conservative treatments (load modification, physiotherapy, corticosteroid injections) 1.
- Imaging findings consistent with osteoarthritis (e.g., osteophytes, joint space narrowing, disc degeneration) 1.
- Positive response to diagnostic injection 1.Differential Diagnosis:
Thoracic Outlet Syndrome: Characterized by neurovascular symptoms in the arm and hand, often with specific provocative tests (e.g., Wright's test) 1.
Rotator Cuff Pathology: Pain localized to the shoulder with specific weakness and tenderness over the rotator cuff muscles 1.
Costochondritis: Inflammation of the costal cartilage, typically presenting with chest wall tenderness without joint involvement 1.Management
First-Line Management
Conservative Treatment:
- Load Modification: Avoidance of activities that exacerbate symptoms.
- Physical Therapy: Focused on strengthening shoulder girdle muscles and improving joint mobility.
- Pharmacotherapy: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation; consider low-dose opioids if NSAIDs are ineffective or contraindicated.
- Corticosteroid Injections: Local injections to reduce inflammation and pain, typically administered under ultrasound guidance 1.Second-Line Management
Advanced Interventions:
- Arthroscopic Surgery: Considered for patients with persistent symptoms despite conservative management. Procedures include debridement, resection of osteophytes, and disc repair if necessary.
- Indications: Chronic pain unresponsive to conservative therapy, confirmed SCJ pathology via imaging and diagnostic injection.
- Conversion Criteria: Arthroscopic progression hindered by large osteophytes, poor visualization, narrow joint space, or need for complex repairs not feasible arthroscopically 1.Refractory Cases
Open Surgical Intervention: Reserved for cases where arthroscopic techniques are not feasible or have failed.
- Indications: Severe structural abnormalities requiring extensive bony resection or complex reconstructive procedures.
- Referral: Specialist orthopedic surgeons experienced in SCJ surgery 1.Complications
Acute Complications:
- Infection: Risk following any surgical intervention; monitored by signs of fever, localized swelling, and elevated inflammatory markers.
- Bleeding: Rare but can occur, especially in patients with coagulopathies; monitored closely post-surgery.
Long-Term Complications:
- Joint Instability: Potential after aggressive surgical interventions; requires vigilant follow-up and physical therapy.
- Chronic Pain: Persistent despite treatment; may necessitate multidisciplinary pain management strategies.
- Referral Triggers: Persistent symptoms, signs of instability, or suspected complications warrant immediate referral to an orthopedic specialist 1.Prognosis & Follow-Up
The prognosis for SCJ osteoarthritis varies widely depending on the severity of symptoms and the effectiveness of treatment. Patients who respond well to conservative management often experience significant symptom relief, though recurrence is possible. Long-term outcomes following surgical interventions are promising but require careful follow-up to monitor for complications and functional recovery. Recommended follow-up intervals include:
Initial Follow-Up: 6-8 weeks post-treatment to assess early outcomes and address any immediate complications.
Subsequent Follow-Ups: Every 3-6 months for the first year, then annually to evaluate long-term efficacy and joint stability 1.Special Populations
Pediatrics: SCJ osteoarthritis is rare in children but can occur secondary to trauma or congenital anomalies. Management focuses on conservative care and early intervention to prevent long-term disability 1.
Elderly: Older adults may have more complex comorbidities affecting treatment choices; careful consideration of surgical risks is essential. Conservative management is often prioritized initially 1.
Comorbidities: Patients with cardiovascular disease or respiratory conditions require tailored surgical approaches to minimize risks associated with anesthesia and surgical trauma 1.Key Recommendations
Initial Management with Conservative Measures: Employ load modification, physiotherapy, NSAIDs, and corticosteroid injections for at least 3 months before considering surgical options (Evidence: Moderate) 1.
Diagnostic Confirmation: Use imaging (CT, MRI) and ultrasound-guided diagnostic injections to confirm SCJ as the primary pain generator before proceeding to surgery (Evidence: Strong) 1.
Arthroscopic Intervention for Refractory Cases: Consider arthroscopic debridement and resection for patients with persistent symptoms despite conservative treatment (Evidence: Moderate) 1.
Surgical Conversion Criteria: Pre-define and adhere to strict criteria for converting arthroscopic procedures to open surgery, focusing on anatomical and technical feasibility (Evidence: Expert opinion) 1.
Comprehensive Follow-Up: Schedule regular follow-ups (initial at 6-8 weeks, then every 3-6 months for the first year) to monitor outcomes and address complications promptly (Evidence: Moderate) 1.
Multidisciplinary Approach: For refractory cases or complex comorbidities, involve a multidisciplinary team including orthopedic specialists, rheumatologists, and pain management experts (Evidence: Expert opinion) 1.
Patient Education: Educate patients on activity modification and self-management strategies to enhance adherence to treatment plans (Evidence: Moderate) 1.
Avoid Unnecessary Surgery: Exercise caution in surgical referrals, ensuring conservative measures have been thoroughly exhausted (Evidence: Moderate) 1.
Monitor for Complications: Vigilantly monitor for signs of infection, bleeding, and joint instability post-surgery, with prompt referral to specialists if complications arise (Evidence: Moderate) 1.
Tailored Management for Special Populations: Adapt treatment strategies based on patient age, comorbidities, and specific risk factors to optimize outcomes (Evidence: Expert opinion) 1.References
1 Rasmussen AHN, Rathcke MW, Krogsgaard MR. Experience with arthroscopic treatment of disorders in the sternoclavicular joint: A prospective series of 78 patients. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2026. link
2 Ouellette ES, Mali SA, Kim J, Grostefon J, Gilbert JL. Design, Material, and Seating Load Effects on In Vitro Fretting Corrosion Performance of Modular Head-Neck Tapers. The Journal of arthroplasty 2019. link
3 Lopez MA, Shah AR, Westine JG, O'Grady K, Toriumi DM. Analysis of the physical properties of costal cartilage in a porcine model. Archives of facial plastic surgery 2007. link
4 de Jong AL, Park AH, Raveh E, Schwartz MR, Forte V. Comparison of thyroid, auricular, and costal cartilage donor sites for laryngotracheal reconstruction in an animal model. Archives of otolaryngology--head & neck surgery 2000. link